NCT05043155

Brief Summary

A short survey involving 100 participants was conducted online to explore the understanding of Covid 19 pandemic impact and importance of vaccination among cancer survivors.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2021

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2021

Completed
12 days until next milestone

First Submitted

Initial submission to the registry

September 13, 2021

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 14, 2021

Completed
Last Updated

September 14, 2021

Status Verified

September 1, 2021

Enrollment Period

8 months

First QC Date

September 13, 2021

Last Update Submit

September 13, 2021

Conditions

Covid19Vaccination RefusalSurvivorship

Keywords

Covid19VaccinationGynaeoncology cancerCancer survivor

Outcome Measures

Primary Outcomes (2)

  • Vaccination refusal

    Number of cancer survivors refuse vaccine

    8 months

  • Reason for Refusal of Vaccine

    Number of cancer survivors refuse vaccine

    8 months

Eligibility Criteria

Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsFemale cancer survivors
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Female cancer survivors or care-taker undergoing national covid 19 vaccine

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dept O&G, UKM Medical Centre

Kuala Lumpur, 56000, Malaysia

Location

MeSH Terms

Conditions

COVID-19Vaccination Refusal

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract DiseasesTreatment RefusalTreatment Adherence and ComplianceHealth BehaviorBehavior

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor Dr

Study Record Dates

First Submitted

September 13, 2021

First Posted

September 14, 2021

Study Start

January 1, 2021

Primary Completion

September 1, 2021

Study Completion

September 1, 2021

Last Updated

September 14, 2021

Record last verified: 2021-09

Locations

MY(1)